In vitro metabolism of a novel JNK inhibitor tanzisertib: interspecies differences in oxido-reduction and characterization of enzymes involved in metabolism

References

• Alcorn JF, van der Velden J, Brown AL, et al. (2009). c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis. Am J Respir Cell Mol Biol 40:422–32
   PubMed Web of Science ®Google Scholar
• Beseda I, Czollner L, Shah PS, et al. (2010). Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases. Bioorg Med Chem 18:433–54
   PubMed Web of Science ®Google Scholar
• Birtwistle J, Hayden RE, Khanim FL, et al. (2009). The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: implications for leukemogenesis. Mutat Res 662:67–74
   PubMed Web of Science ®Google Scholar
• Bogoyevitch MA, Kobe B. (2006). Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiol Mol Biol Rev 70:1061–95
   PubMed Web of Science ®Google Scholar
• Chen WD, Zhang Y. (2012). Regulation of aldo-keto reductases in human diseases. Front Pharmacol 3:35 doi: 10.3389/fphar.2012.00035
   PubMedGoogle Scholar
• Davis RJ. (2000). Signal transduction by the JNK group of MAP kinases. Cell 103:239–52
   PubMed Web of Science ®Google Scholar
• Eferl R, Hasselblatt P, Rath M, et al. (2008). Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1. Proc Natl Acad Sci USA 105:10525–30
   PubMed Web of Science ®Google Scholar
• Fung KM, Samara EN, Wong C, et al. (2006). Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma. Endocr Relat Cancer 13:169–80
   PubMedGoogle Scholar
• Hashimoto S, Gon Y, Takeshita I, et al. (2001). Transforming growth Factor-beta1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway. Am J Respir Crit Care Med 163:152–7
   PubMed Web of Science ®Google Scholar
• Jin Y, Mesaros AC, Blair IA, Penning TM. (2011). Stereospecific reduction of 5beta-reduced steroids by human ketosteroid reductases of the AKR (aldo-keto reductase) superfamily: role of AKR1C1-AKR1C4 in the metabolism of testosterone and progesterone via the 5beta-reductase pathway. Biochem J 437:53–61
   PubMed Web of Science ®Google Scholar
• Johnston CJ, Oberdorster G, Gelein R, Finkelstein JN. (2002). Endotoxin potentiates ozone-induced pulmonary chemokine and inflammatory responses. Exp Lung Res 28:419–33
   PubMed Web of Science ®Google Scholar
• Lin HK, Steckelbroeck S, Fung KM, et al. (2004). Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate. Steroids 69:795–801
   PubMed Web of Science ®Google Scholar
• Ma FY, Flanc RS, Tesch GH, et al. (2007). A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis. J Am Soc Nephrol 18:472–84
   PubMed Web of Science ®Google Scholar
• Mahadevan D, DiMento J, Croce KD, et al. (2006). Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia. Am J Hematol 81:779–86
   PubMed Web of Science ®Google Scholar
• Penning TM, Burczynski ME, Jez JM, et al. (2000). Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J 351:67–77
   PubMed Web of Science ®Google Scholar
• Penning TM, Byrns MC. (2009). Steroid hormone transforming aldo-keto reductases and cancer. Ann N Y Acad Sci 1155:33–42
   PubMed Web of Science ®Google Scholar
• Rizner TL, Lin HK, Peehl DM, et al. (2003). Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells. Endocrinology 144:2922–32
   PubMed Web of Science ®Google Scholar
• Stanbrough M, Bubley GJ, Ross K, et al. (2006). Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res 66:2815–25
   PubMed Web of Science ®Google Scholar
• Steckelbroeck S, Oyesanmi B, Jin Y, et al. (2006). Tibolone metabolism in human liver is catalyzed by 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four isoforms of the aldo-keto reductase (AKR)1C subfamily. J Pharmacol Exp Ther 316:1300–9
   PubMed Web of Science ®Google Scholar
• Wong CK, Wong PT, Tam LS, et al. (2009). Activation profile of intracellular mitogen-activated protein kinases in peripheral lymphocytes of patients with systemic lupus erythematosus. J Clin Immunol 29:738–46
   PubMedGoogle Scholar
• Zhang C, Kawauchi J, Adachi MT, et al. (2001). Activation of JNK and transcriptional repressor ATF3/LRF1 through the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine. Biochem Biophys Res Commun 289:718–24
   PubMed Web of Science ®Google Scholar